These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34224097)
1. The Opportunities and Challenges of Molecular Tagging Next-Generation Sequencing in Liquid Biopsy. De Luca G; Dono M Mol Diagn Ther; 2021 Sep; 25(5):537-547. PubMed ID: 34224097 [TBL] [Abstract][Full Text] [Related]
2. Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice. Gašperšič J; Videtič Paska A Biochem Med (Zagreb); 2020 Oct; 30(3):030504. PubMed ID: 32774122 [TBL] [Abstract][Full Text] [Related]
3. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics. Song P; Wu LR; Yan YH; Zhang JX; Chu T; Kwong LN; Patel AA; Zhang DY Nat Biomed Eng; 2022 Mar; 6(3):232-245. PubMed ID: 35102279 [TBL] [Abstract][Full Text] [Related]
5. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients. Macías M; Cañada-Higueras E; Alegre E; Bielsa A; Gracia J; Patiño-García A; Ferrer-Costa R; Sendino T; Andueza MP; Mateos B; Rodríguez J; Corral J; Gúrpide A; Lopez-Picazo JM; Perez-Gracia JL; Gil-Bazo I; Alkorta-Aranburu G; González Á Clin Chem Lab Med; 2020 Jul; 58(8):1341-1348. PubMed ID: 32623849 [TBL] [Abstract][Full Text] [Related]
6. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma. Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033 [TBL] [Abstract][Full Text] [Related]
7. Duplex Proximity Sequencing (Pro-Seq): A method to improve DNA sequencing accuracy without the cost of molecular barcoding redundancy. Pel J; Choi WWY; Leung A; Shibahara G; Gelinas L; Despotovic M; Ung WL; Marziali A PLoS One; 2018; 13(10):e0204265. PubMed ID: 30278055 [TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141 [TBL] [Abstract][Full Text] [Related]
9. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer. Bennett CW; Berchem G; Kim YJ; El-Khoury V Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834 [TBL] [Abstract][Full Text] [Related]
10. Quantifying sequencing error and effective sequencing depth of liquid biopsy NGS with UMI error correction. Frank MS; Fuß J; Steiert TA; Streleckiene G; Gehl J; Forster M Biotechniques; 2021 Apr; 70(4):226-232. PubMed ID: 33512245 [TBL] [Abstract][Full Text] [Related]
11. Integration of Liquid Biopsies into Clinical Laboratory Applications via NGS in Cancer Diagnostics. Sonmezler O; Boga I; Bisgin A Clin Lab; 2020 May; 66(5):. PubMed ID: 32390404 [TBL] [Abstract][Full Text] [Related]
12. Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients. Wang B; Wu S; Huang F; Shen M; Jiang H; Yu Y; Yu Q; Yang Y; Zhao Y; Zhou Y; Pan B; Liu T; Guo W Clin Chem Lab Med; 2019 Sep; 57(10):1501-1510. PubMed ID: 31339850 [TBL] [Abstract][Full Text] [Related]
13. Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study. Alborelli I; Generali D; Jermann P; Cappelletti MR; Ferrero G; Scaggiante B; Bortul M; Zanconati F; Nicolet S; Haegele J; Bubendorf L; Aceto N; Scaltriti M; Mucci G; Quagliata L; Novelli G Cell Death Dis; 2019 Jul; 10(7):534. PubMed ID: 31296838 [TBL] [Abstract][Full Text] [Related]
14. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas. Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914 [TBL] [Abstract][Full Text] [Related]
15. Gencore: an efficient tool to generate consensus reads for error suppressing and duplicate removing of NGS data. Chen S; Zhou Y; Chen Y; Huang T; Liao W; Xu Y; Li Z; Gu J BMC Bioinformatics; 2019 Dec; 20(Suppl 23):606. PubMed ID: 31881822 [TBL] [Abstract][Full Text] [Related]
16. UMIErrorCorrect and UMIAnalyzer: Software for Consensus Read Generation, Error Correction, and Visualization Using Unique Molecular Identifiers. Österlund T; Filges S; Johansson G; Ståhlberg A Clin Chem; 2022 Nov; 68(11):1425-1435. PubMed ID: 36031761 [TBL] [Abstract][Full Text] [Related]
17. Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience. Bonanno L; Pavan A; Ferro A; Calvetti L; Frega S; Pasello G; Aprile G; Guarneri V; Conte P; Oncologist; 2020 Dec; 25(12):e1996-e2005. PubMed ID: 32557976 [TBL] [Abstract][Full Text] [Related]